Clinical trial
Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors
NCT00021346 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00021346 |
|---|---|
| Title | Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Evaluation Of Carboplatin And Gemcitabine |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | carboplatin, gemcitabine hydrochloride |
| Enrollment | 8 |
| Start date | Nov 1, 1997 |
| Primary completion | Jul 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Apr 22, 2004 |
| Last update posted | Apr 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: